Hydroxychloroquine use: the potential impact of new ocular screening guidelines
Eye (Lond)
.
2018 Jan;32(1):161-162.
doi: 10.1038/eye.2017.166.
Epub 2017 Aug 11.
Authors
M Yates
1
,
R Malaiya
2
,
J Stack
2
,
J B Galloway
1
Affiliations
1
Department of Academic Rheumatology, King's College London, Weston Education Centre, London, UK.
2
Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, UK.
PMID:
28799559
PMCID:
PMC5770712
DOI:
10.1038/eye.2017.166
No abstract available
Publication types
Letter
MeSH terms
Antirheumatic Agents / therapeutic use
Humans
Hydroxychloroquine / therapeutic use*
Practice Guidelines as Topic*
Retinal Diseases / drug therapy*
Substances
Antirheumatic Agents
Hydroxychloroquine